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General procedure A: Sodium (0.70 g, 30 mmol, 1.5 eq.), cyclopropylmethanol (20 mL, 247 mmol), 4-chloro-2,6-diaminopyrimidine (0.86 g, 5.9 mmol), at 140 °C. Gave 3c as a yellow oil (4.878 g, 96.7%). UV λ max (EtOH) 
2,6-Diamino-4-heptoxypyrimidine (3e).
A mixture of heptan-1-ol (1.1 ml, 7.8 mmol) and sodium hydride (0.10 g, 4.3 mmol) in DMSO (4 ml) was stirred at rt for 30 min. 4-Chloro-2,6-diaminopyrimidine (0.21 g, 1.4 mmol) was added, and the mixture was heated at 85 C for 4 days. The reaction mixture was allowed to cool to rt and then neutralised with glacial acetic acid; the solvents were removed in vacuo. Chromatography (silica; 10% MeOH, DCM) gave 3e as a cream solid (0.14 g, 43%) m. 
General Procedure B
A mixture of 5-bromo-6-cyclohexylmethoxypyrimidine-2,4-diamine (5) (0.6 g, 1.99 mmol, 1.0 eq.), the appropriate aryl or heteroaryl boronic acid (2.39 mmol, 1.2 eq.), tetrakis(triphenylphosphine)palladium(0) (0.115 g, 0.1 mmol, 5% mol
6-Cyclohexylmethoxy-5-(thiophen-2-yl)pyrimidine-2,4-diamine (7c)
General procedure B: 2-thiophene boronic acid (0.27 g, 2.39 mmol, 1.2 eq. 26.9, 30.1, 37.8, 71.8, 86.9, 126.0, 127.0, 127.6, 135.1, 161.8, 163.6, 168 
General procedure C
A mixture of 6-amino-2-(n-butylsulfanyl)-4(3H)-pyrimidinone (15) (1 eq.), the appropriate alcohol (1.5 eq.), and triphenylphosphine (1.5 eq.) in THF (anh) was stirred at 5 °C in an ice-bath and diethyl azodicarboxylate (1.5 eq.) was added dropwise. The resulting mixture was allowed to stir at rt for 72 h then concentrated in vacuo to yield a yellow oil, which was triturated with Et 2 O in an ice-bath at 0 °C, giving a white precipitate which was removed by filtration. The filtrate was concentrated in vacuo, water (30 mL) was added and the mixture was extracted with EtOAc (3 x 30 mL).
The combined organic layers were dried (Na 2 SO 4 ) and concentrated in vacuo. Chromatography (silica; 20-80% EtOAc, petrol) and recrystallisation (MeOH) gave the desired product 16a-c.
6-sec-Butoxy-2-(n-butylsulfanyl)pyrimidin-4-amine (16b) 13.5, 19.4, 21.6, 28.5, 29.6, 31.6, 72.4, 82.1, 165,2, 168,4, 169 
General Procedure D
To a solution of the appropriate 2-(n-butylsulfanyl)-6-alkoxyoxypyrimidin-4-amine (16a-c) (1 eq.) in DCM under N 2 , m-CPBA (2.5-3 eq.) was added slowly. The resulting mixture was stirred at rt for 24 h, then concentrated in vacuo. The residue was extracted with EtOAc (3 x 30 mL). The combined organic fractions were washed with aq. sodium sulfite (sat.; 30 mL), aq. sodium bicarbonate (sat.; 2 x 30 mL) and water (2 x 30 mL), dried (Na 2 SO 4 ) and concentrated in vacuo to give a white solid. Chromatography (silica; 20-80% EtOAc, petrol) gave 17a-c as a white solid.
6-sec-Butoxy-2-(n-butylsulfonyl)pyrimidin-4-amine (17b) 
General procedure E
A solution of the required pyrimidine (0.50 g, 2.62 mmol, 1 eq.) and the chosen aniline (5.76 mmol, 2.2 eq.) in trifluoroethanol (10 mL) with trifluoroacetic acid (1.0 mL, 13.1 mmol, 5 eq.) was stirred for 48h at rt or heated at reflux 24h as specified. The solvents were removed in vacuo, water (30 mL) was added and the pH was adjusted to neutral with saturated aq. sodium bicarbonate and the mixture was extracted with EtOAc (3 x 30 mL). The combined organic layers were washed with water (2 x 30 mL) and dried (Na 2 SO 4 ), and the solvent was removed in vacuo. The compounds were purified as specified.
4-Amino-6-chloro-2-(4-methoxyphenylamino)-5-formylpyrimidine (21b)
General procedure E: 4-amino-2,6-dichloro-5-formylpyrimidine (20) (0.5 g, 2.62 mmol), p-anisidine (0.71 g, 5.76 mmol,), trifluoroacetic acid (0.48 mL, 6.51 mmol) and trifluoroethanol (10 mL). Chromatography (silica, 20-80% EtOAc, petrol) and recrystallisation (methanol), gave the 21b as a dark yellow solid (0.61 g, 83.6%) m. , 3.98; N, 20.10%. Found C, 51.95; H, 3.95, N, 19 .91%.
Neopentyl 4-(4-amino-6-chloro-5-formylpyrimidin-2-ylamino)benzoate (21c)
General procedure E: 4-amino-2,6-dichloro-5-formylpyrimidine (20) 
4-(4-Amino-6-sec-butoxypyrimidin-2-ylamino)benzenesulfonamide (18b)
General procedure E: 6-sec-Butoxy-2-(n-butylsulfonyl)pyrimidin-4-amine (17b) (0.6 g, 2.09 mmol) and 4-aminobenzensulfonamide (0.72 g, 4.17 mmol) in TFE (6 mL) with TFA (0.8 mL, 10.4 mmol), heated at reflux for 24 h. 
4-(4-Amino-6-ethoxypyrimidin-2-ylamino)benzensulfonamide (18c)
General procedure E: 2-(n-Butylsulfonyl)-6-ethoxypyrimidin-4-amine (17c) (0.6 g, 2.32 mmol) and 4-aminobenzensulfonamide (0.60 g, 3.47 mmol), TFE (8 mL), TFA (0.89 mL, 11.6 mmol), heated at reflux for 24 h.
Chromatography (silica; 20-95% EtOAc, 5% formic acid, petrol) gave 18c as a white solid (0.45 g, 63%) m. 
General Procedure F
The chosen alcohol (10 eq.) was added dropwise to a suspension of sodium hydride (5 eq.) in THF (anh; 5 mL), and the mixture was stirred at rt under N 2 for 30 min. The chosen 4-amino-6-chloro-2-(arylamino)-5-formylpyrimidine (1 eq.) was added slowly, in small portions and the reaction mixture was heated at reflux 16 h, the allowed to cool to rt, quenched with water (10 mL), and acidified (2 M HCl) to pH < 2, then THF (10 mL) was added, the resulting mixture was stirred overnight, neutralised (saturated aq. sodium bicarbonate), and concentrated in vacuo. The residue was extracted with EtOAc (4 x 30 mL) and the combined organic layers were dried (Na 2 SO 4 ), and concentrated in vacuo to
give a yellow-orange oil. Chromatography (silica; 40-100% EtOAc, petrol, or 10% MeOH, DCM) and recrystallisation (methanol) or HPLC purification, gave the product as a white solid.
4-Amino-6-ethoxy-2-(4-methoxyphenylamino)-5-formylpyrimidine (22b)
General procedure F: 4-amino-6-chloro-2-(4-methoxyphenylamino)-5-formylpyrimidine (21b) 55.5, 62.6, 93.8, 114.2, 122.8, 131.6, 156.4, 160.8, 164.6, 171.9, 186.6 
4-Amino-6-isopropoxy-2-(4-methoxyphenylamino)-5-formylpyrimidine (22c)
Supplementary Material (ESI) for Organic & Biomolecular Chemistry This journal is (c) The Royal Society of Chemistry 2010 General procedure F: 4-amino-6-chloro-2-(4-methoxyphenylamino)-5-formylpyrimidine (21b) (0.20 g, 0.72 mmol), isopropanol (0.55 mL, 7.2 mmol). Chromatography (silica; 50-100% EtOAc, petrol) and recrystallisation (ethanol)
4-Amino-6-sec-butoxy-2-(4-methoxyphenylamino)-5-formylpyrimidine (22d)
General procedure F: 4-amino-6-chloro-2-(4-methoxyphenylamino)-5-formylpyrimidine (21b) 
4-(4-amino-6-(cyclohexylmethoxy)-5-formylpyrimidin-2-ylamino)benzoic acid. (22e)
General procedure F: neopentyl 4-(4-amino-6-chloro-5-formylpyrimidin-2-ylamino)benzoate (21c) (0.50 g, 1.38 mmol), cyclohexylmethanol (1.7 mL, 13.8 mmol). After cooling to rt, the reaction was quenched with water (5 mL), basified to pH > 12 (2M NaOH), extracted with EtOAc (3 x 30 mL), then acidified to pH < 2 (4M HCl), and extracted with EtOAc (3 x 40 mL). The combined organic fractions were washed with water (2 x 20 mL), dried (Na 2 SO 4 ) and concentrated in vacuo. Recrystallisation (EtOAc) gave 22e as an off-white solid (0.27 g, 53% 
4-(4-Amino-6-ethoxy-5-formylpyrimidin-2-ylamino)benzenesulfonamide (22f)
General procedure F: 4-(4-amino-6-chloro-5-formylpyrimidin-2-ylamino)benzenesulfonamide (21a) H, 4.48; N, 20.76%; found C, 46.09; H, 4.47, N, 20 .36%.
4-(4-Amino-5-formyl-6-isopropyloxypyrimidin-2-ylamino)benzenesulfonamide (22g)
General procedure F: 4-(4-amino-6-chloro-5-formylpyrimidin-2-ylamino)benzenesulfonamide (21a) 
(R)-4-(4-Amino-6-sec-butoxy-5-formylpyrimidin-2-ylamino)benzenesulfonamide (22i)
General procedure F: 4-(4-amino-6-chloro-5-formylpyrimidin-2-ylamino)benzenesulfonamide (21a) 8, 19.7, 29.9, 76.0, 89.7, 120.9, 127.9, 136.7, 144.3, 155.6, 162.1, 172.3, 188 
4-(4-

General Procedure G
The appropriate O 4 -substituted pyrimidine (1 eq.) was dissolved in 30% aq. acetic acid (1 ml -4 ml) at rt. The temperature was increased to 80 C and sodium nitrite (1.3 eq.) in water (1 ml -3 ml) was added dropwise to give a purple precipitate. The reaction was maintained at 80 C for 40 min, allowed to cool to rt and the precipitate was collected by filtration. The crude product was purified by recrystallisation from the appropriate solvent.
6-Ethoxy-5-nitrosopyrimidine-2,4-diamine (4b)
General Procedure G: ethoxypyrimidine-2,4-diamine (3b) (0. 14.6, 63.1, 140.0, 151.5, 163.8, 170.8; MS (ESI+) 6-sec-Butoxy-5-nitrosopyrimidine-2,4-diamine (4d)
General Procedure G: 6-sec-butoxypyrimidine-2,4-diamine (3d) (0.2 g, 1.1 mmol, 1 eq.), 30% aqueous acetic acid (1.5 mL), sodium nitrite (0.114 g, 1.65 mmol, 1.5 eq.) in water (0.3 mL 
4-(4-Amino-6-ethoxy-5-nitrosopyrimidin-2-ylamino)benzenesulfonamide (20d)
General Procedure G: 4-(4-amino-6-ethoxypyrimidin-2-ylamino)benzensulfonamide (18c) (0.12 g, 0.388 mmol, 1 eq.), 30% aqueous acetic acid (5 mL), sodium nitrite (32 mg, 0.465 mmol, 1.2 eq.), water (0.35 mL 
General Procedure H
To a solution of formylpyrimidine (22) (0.17 mmol) in EtOH (anh; 3 mL) was added hydroxylamine hydrochloride (0.014 g, 0.202 mmol), followed by pyridine (anh., 0.016 mL, 0.202 mmol) and the mixture was stirred 16h at rt under N 2 , then concentrated in vacuo. The residues were diluted with water (30 mL) and extracted with EtOAc (3 x 40 mL).
The combined organic layers were dried(Na 2 SO 4 ) and concentrated in vacuo.
4-(4-Amino-6-cyclohexylmethoxy-5-hydroxyiminomethyl)pyrimidin-2-ylamino)benzenesulfonamide (23b)
General Procedure H: 4-(4-amino-6-cyclohexylmethoxy-5-formylpyrimidin-2-ylamino)benzenesulfonamide (22k) (0.05 g, 0.12 mmol). Recrystallisation (methanol) gave 23b as a white solid (0.044 g, 85%) m.p. 134-136 °C.
UV λ max (EtOH): 318, 261 and 219 nm; IR  max 3410, 3315, 3127, 2921, 2851, 1570, 1514, 1445, 1309, 1146 , 947 cm 8, 27.6, 30.9, 38.8, 73.0, 87.2, 119.5, 128.0, 136.8, 145.6, 146.1, 159.4, 163.6, 169.4 4-(4-Amino-6-sec-butoxy-5-(hydroxyiminomethyl)pyrimidin-2-ylamino)benzenesulfonamide (23c)
General Procedure H: 4-(4-amino-6-sec-buthoxy-5-formylpyrimidin-2-ylamino)benzenesulfonamide (22h) (20 mg, 54.8 µmol, 1 eq. 
